Skip to main content
Universal Drugstore logo

Can Jardiance Help Heart Health?

Can Jardiance help heart health? This question has become increasingly important as research reveals that Jardiance (empagliflozin), originally developed for type 2 diabetes, offers significant benefits for cardiovascular conditions. Clinical trials show this medication can reduce the risk of heart-related hospitalizations and deaths, leading to FDA approval for specific heart conditions.

Shop Medications

,

Understanding how Jardiance works for heart health requires looking beyond its original purpose. While many people know it as a diabetes medication, empagliflozin has proven effects on the cardiovascular system that extend far beyond blood sugar control.

In This Article

How Jardiance Works for Heart Health

Jardiance belongs to a class of medications called SGLT2 inhibitors. These drugs work by blocking sodium-glucose cotransporter-2 proteins in the kidneys, which normally reabsorb glucose back into the bloodstream. By blocking this process, the medication helps remove excess glucose through urine.

For heart health, the benefits go beyond glucose control. The medication appears to reduce the workload on the heart by decreasing fluid retention and lowering blood pressure. It also seems to improve how efficiently the heart pumps blood, though researchers are still studying the exact mechanisms.

The cardiovascular effects occur regardless of whether a person has diabetes. This discovery led researchers to test empagliflozin specifically in people with heart conditions but without diabetes, yielding promising results.

FDA-Approved Heart Health Uses

The FDA has approved Jardiance for two specific heart-related conditions beyond diabetes management.

Heart Failure with Reduced Ejection Fraction
In this condition, the heart muscle becomes weakened and cannot pump blood effectively. The heart’s ejection fraction, which measures how much blood the heart pumps out with each beat, falls below normal levels. Jardiance helps reduce the risk of cardiovascular death and hospitalization in these patients.

Heart Failure with Preserved Ejection Fraction
Some people develop heart failure symptoms even though their heart’s pumping function appears normal on tests. This condition, called heart failure with preserved ejection fraction, affects millions of Americans. Research shows Jardiance can help these patients, too.

Clinical Trial Evidence

Multiple large-scale clinical trials have demonstrated that Jardiance can help heart health. The most significant studies include the EMPEROR-Reduced and EMPEROR-Preserved trials, which tested empagliflozin in thousands of heart failure patients.

EMPEROR-Reduced Trial Results
This study involved nearly 4,000 people with heart failure and reduced ejection fraction. Participants who took Jardiance experienced a 25% lower risk of cardiovascular death or heart failure hospitalization compared to those taking a placebo.

EMPEROR-Preserved Trial Results
The EMPEROR-Preserved trial studied over 5,900 people with heart failure and preserved ejection fraction. Results showed a 21% reduction in the combined risk of cardiovascular death or heart failure hospitalization among those taking empagliflozin.

Benefits Across Different Patient Groups
Importantly, these heart health benefits occurred whether or not participants had diabetes. This finding suggests that the cardiovascular effects of Jardiance work through mechanisms independent of blood sugar control.

Who Might Benefit from Jardiance for Heart Health

Healthcare providers may consider Jardiance for patients with specific heart conditions, particularly those diagnosed with heart failure. The medication has shown benefits across different demographics and severity levels.

Heart Failure Patients
People diagnosed with either type of heart failure may be candidates for Jardiance therapy. This includes both newly diagnosed patients and those whose symptoms persist despite other treatments.

High Cardiovascular Risk Patients
Some patients with multiple risk factors for heart disease might benefit from Jardiance, even before developing heart failure. However, this use requires careful evaluation by a healthcare provider.

Patients with and without Diabetes
Unlike many heart medications, Jardiance has proven benefits regardless of diabetes status. This makes it unique among SGLT2 inhibitors and expands its potential use for heart health.

How Jardiance Compares to Other Heart Medications

Jardiance represents a newer approach to heart failure treatment. Traditional heart failure medications include ACE inhibitors, beta-blockers, and diuretics. Each works differently to support heart function.

Complementary Effects
Rather than replacing existing heart medications, Jardiance typically works alongside them. Many patients take multiple heart medications simultaneously, each targeting different aspects of heart failure.

Unique Benefits
What sets Jardiance apart is its dual action on both glucose levels and cardiovascular function. This makes it particularly valuable for patients with both diabetes and heart conditions.

Potential Side Effects and Considerations

Like all medications, Jardiance can cause side effects. Understanding these helps patients and healthcare providers make informed treatment decisions.

Common Side Effects

  • Urinary tract infections
  • Increased urination
  • Yeast infections (more common in women)

Serious but Rare Side Effects
Ketoacidosis, a dangerous buildup of acids in the blood, occurs in less than 1% of patients. Severe kidney problems and serious infections in the genital area are also rare but possible complications.

Who Should Avoid Jardiance
People with severe kidney disease, those on dialysis, and individuals with type 1 diabetes should typically not use this medication. Pregnant or breastfeeding women should also avoid empagliflozin.

Working with Healthcare Providers

Determining whether Jardiance can help your heart health requires professional medical evaluation. Healthcare providers consider multiple factors when making treatment recommendations.

Necessary Tests
Before starting Jardiance, providers typically order kidney function tests, blood pressure measurements, and heart function assessments. These baseline values help monitor treatment effects.

Ongoing Monitoring
Regular follow-up appointments allow healthcare providers to assess how well the medication is working and watch for any side effects. Blood tests and heart function evaluations may be repeated periodically.

Lifestyle Considerations
Jardiance works best as part of a comprehensive heart health plan. This often includes dietary changes, exercise recommendations, and other medications as appropriate for each individual patient.

Cost and Access Considerations

The cost of Jardiance can vary significantly depending on insurance coverage and pharmacy choice. Many patients find that exploring different payment options helps make the medication more affordable.

For those paying cash or seeking lower-cost alternatives, Universal Drugstore offers a reliable way to access empagliflozin at competitive prices. This can be particularly helpful for patients whose insurance doesn’t cover the medication or who face high copayments.

Insurance Coverage
Most insurance plans cover Jardiance for FDA-approved uses, including heart failure indications. However, prior authorization may be required, and copayments vary by plan.

The Future of Jardiance in Heart Health

Ongoing research continues to explore new ways that Jardiance might help heart health. Scientists are studying its effects in different patient populations and investigating combination therapies.

Current studies examine whether Jardiance might help prevent heart problems in high-risk patients who don’t yet have heart failure. Researchers are also exploring optimal dosing strategies and treatment duration.

Making an Informed Decision

Can Jardiance help heart health? The answer depends on individual circumstances, but clinical evidence strongly supports its benefits for specific heart conditions. The medication has proven effective in reducing cardiovascular death and heart failure hospitalizations across diverse patient populations.

For people with heart failure, whether with reduced or preserved ejection fraction, Jardiance represents an evidence-based treatment option. The benefits occur regardless of diabetes status, making it valuable for a broad range of patients.

However, like all medical decisions, choosing Jardiance requires careful consideration of individual health status, other medications, and potential risks. Working closely with a healthcare provider ensures that any treatment plan aligns with personal health goals and circumstances.

The research clearly shows that this diabetes medication offers real cardiovascular benefits. For many patients with heart conditions, Jardiance can be an important part of a comprehensive approach to heart health management.

References

Related Conditions